drugset / Trial / NCT03034356
Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia
RandomizedCrossoverTriple-blindOther
Summary
This study plans to learn more about the effects of levetiracetam (LEV) on brain activity and cognition in schizophrenia and schizoaffective disorder. Levetiracetam is an anti-seizure drug, also called an anticonvulsant.
Timeline
- Start
- 2018-09-01
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levetiracetam | Other / unclassified | 125 mg | Oral |